SUMMIT HOTEL PROPERTIES REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS
INNAccretive Capital Recycling Continues with the Sale of the Hilton Garden Inn Longview Refinance of Convertible Notes Complete Utilizing Delayed Draw Term Loan No Debt Maturities Until 2028 AUSTIN, Texas, Feb. 25, 2026 /PRNewswire/ -- Summit Hotel Properties, Inc. (NYSE: INN) (the...
SUMMIT HOTEL PROPERTIES ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 EARNINGS RELEASE DATE
INNAUSTIN, Texas, Jan. 12, 2026 /PRNewswire/ -- Summit Hotel Properties, Inc. (NYSE: INN) (the "Company") today announced that it will report financial results for the fourth quarter and full year of 2025 on Wednesday, February 25, 2026, after the market closes. The Company will conduct its...
Number of Shares and Voting Rights of Innate Pharma as of August 1, 2025
INNMARSEILLE, France--(BUSINESS WIRE)--Number of shares and voting rights of Innate Pharma as of August 1, 2025
Summit Hotel Properties Files For Mixed Shelf; Size Not Disclosed
INNSummit Hotel Properties Q1 FFO $0.22 Beats $0.21 Estimate, Sales $184.48M Beat $184.04M Estimate
INNSummit Hotel Properties Sees FY2025 AFFO per common share $0.90-$1.00 vs $0.97 Est
INNSummit Hotel Properties Q4 AFFO per common share $0.20, Inline, Sales $172.93M Beat $172.08M Estimate
INNSummit Hotel Properties Narrows FY2024 FFO Guidance from $0.91-0.99 to $0.92-0.98 vs $0.94 Est
INNSummit Hotel Properties Q3 2024 FFO $0.22 Beats $0.20 Estimate, Sales $176.807M Miss $181.296M Estimate
INN